Found 8 matching trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
University of Arkansas
Learn More & Join Trial
A Study of Sublingual Immunotherapy in Peanut-allergic Children PHASE2 The specific aim of this study is to determine if peanut allergen-specific ...
Show More Location
University of North Carolina
Learn More & Join Trial
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients PHASE1 Primary Objective:
To assess tolerability and safety of SAR439794 \[peanut...
Show More Location
Investigational Site Number 8400004
Learn More & Join Trial
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy PHASE1 This clinical research study investigates the safety, tolerability and effi...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
FARE Peanut SLIT and Early Tolerance Induction PHASE2 Primary Objective: To determine if 36 months of peanut SLIT as an early int...
Show More Location
University of North Carolina at Chapel Hill
Learn More & Join Trial
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance PHASE1 The goal of this study will be to increase the reaction threshold (desensit...
Show More Location
University of North Carolina
Learn More & Join Trial
OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut PHASE1 This is a phase 1, multi-center, randomized, double-blind, placebo-controll...
Show More Location
Hudson-Essex Allergy
Learn More & Join Trial
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy PHASE1 The purpose of this study is to explore the safety and efficacy of a sublin...
Show More Location
Johns Hopkins University
Learn More & Join Trial